Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy? (Q47274422)
Jump to navigation
Jump to search
scientific article published on 2 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy? |
scientific article published on 2 August 2006 |
Statements
1 reference
Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy? (English)
1 reference
James V Donadio
1 reference
Eric J Bergstralh
1 reference
Douglas M Bibus
1 reference
Joseph P Grande
1 reference
2 August 2006
1 reference
1
1 reference
5
1 reference
933-939
1 reference